CenterBook Partners LP Acquires Shares of 17,748 Concentrix Corporation $CNXC

CenterBook Partners LP bought a new position in shares of Concentrix Corporation (NASDAQ:CNXC) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 17,748 shares of the company’s stock, valued at approximately $819,000.

Several other institutional investors have also recently made changes to their positions in the company. Quent Capital LLC bought a new stake in shares of Concentrix during the third quarter valued at approximately $29,000. Geneos Wealth Management Inc. lifted its position in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after buying an additional 522 shares during the period. Rothschild Investment LLC boosted its holdings in shares of Concentrix by 14,980.0% during the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after buying an additional 749 shares in the last quarter. True Wealth Design LLC grew its position in shares of Concentrix by 39.3% in the 2nd quarter. True Wealth Design LLC now owns 1,163 shares of the company’s stock worth $61,000 after buying an additional 328 shares during the period. Finally, Parkside Financial Bank & Trust grew its position in shares of Concentrix by 23.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,818 shares of the company’s stock worth $96,000 after buying an additional 351 shares during the period. Institutional investors own 90.34% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction on Thursday, January 29th. The shares were acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.20% of the company’s stock.

Concentrix Stock Performance

Shares of NASDAQ CNXC opened at $32.85 on Friday. The firm’s 50-day moving average price is $39.49 and its 200-day moving average price is $43.16. Concentrix Corporation has a 52-week low of $29.35 and a 52-week high of $66.00. The company has a market cap of $2.02 billion, a PE ratio of -1.58, a PEG ratio of 0.34 and a beta of 0.50. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.67.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The company had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. During the same quarter in the prior year, the firm earned $3.26 earnings per share. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, analysts anticipate that Concentrix Corporation will post 10.11 EPS for the current year.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date was Friday, January 30th. Concentrix’s dividend payout ratio is -6.91%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Barrington Research reissued an “outperform” rating and set a $62.00 price objective on shares of Concentrix in a research note on Monday, January 12th. Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Robert W. Baird set a $52.00 price target on Concentrix in a research note on Wednesday, January 14th. Finally, Weiss Ratings cut Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $63.75.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.